MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$9,424K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Maturities of available-for-sale...
Amortization of right-of-use ass...
Depreciation and amortization
Others
Negative Cash Flow Breakdown
Purchases of available-for-sale ...
Accounts payable and accrued exp...
Operating lease liability
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Consolidated net loss
-10,310
-10,792
-13,964
-25,746
Depreciation and amortization
168
162
166
165
Stock-based compensation
1,145
1,307
1,207
1,307
Accretion of discount of available-for-sale investment securities
146
255
361
512
Amortization of right-of-use assets
237
232
228
224
Gain on disposal of property and equipment
-
-
12
-
Gain on financing lease bargain purchase option
48
-
-
-
Other receivables
-59
-396
-169
544
Prepaid expenses and other assets
-18
-91
-1,094
-4,795
Accounts payable and accrued expenses
-266
-3,467
-536
18
Operating lease liability
-208
-191
-187
-183
Net cash used in operating activities
-9,351
-12,517
-12,196
-20,476
Purchases of property and equipment
73
138
31
37
Purchases of available-for-sale investment securities
7,978
5,868
12,845
39,340
Maturities of available-for-sale investment securities
23,373
17,500
29,307
19,000
Proceeds from sale of property and equipment
-
-
12
-
Net cash provided by (used in) investing activities
15,322
11,494
16,443
-20,377
Proceeds from issuance of common stock through option exercises
0
0
0
0
Proceeds from issuance of common stock through employee stock purchase plan
16
-
29
0
Proceeds from issuance of common stock from at-the-market offerings, net of offering costs
0
0
-21
29,753
Proceeds from issuance of common stock from underwritten follow-on public offering, net of offering costs
-
-
0
-
Principal paid on finance lease liabilities
145
142
139
136
Net cash (used in) provided by financing activities
-129
-142
-131
29,617
Net change in cash, cash equivalents and restricted cash
5,842
-1,165
4,116
-11,236
Cash, cash equivalents and restricted cash at beginning of period
11,813
12,978
8,862
14,006
Cash, cash equivalents and restricted cash at the end of period
17,655
-
-
-
Cash and cash equivalents at the end of period
16,160
-
-
-
Restricted cash at the end of period
1,495
-
-
-
Cash, cash equivalents and restricted cash at the end of period
17,655
11,813
12,978
8,862
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Maturities of
available-for-sale investment...
$23,373K
(-41.79%↓ Y/Y)
Net cash provided by
(used in) investing...
$15,322K
(1469.26%↑ Y/Y)
Canceled cashflow
$8,051K
Net change in cash,
cash equivalents and...
$5,842K
(-4.10%↓ Y/Y)
Canceled cashflow
$9,480K
Purchases of
available-for-sale investment...
$7,978K
(-80.66%↓ Y/Y)
Purchases of property and
equipment
$73K
(711.11%↑ Y/Y)
Stock-based compensation
$1,145K
(-53.89%↓ Y/Y)
Amortization of right-of-use
assets
$237K
(-45.77%↓ Y/Y)
Depreciation and
amortization
$168K
(-49.55%↓ Y/Y)
Other receivables
-$59K
(95.23%↑ Y/Y)
Prepaid expenses and
other assets
-$18K
(98.75%↑ Y/Y)
Proceeds from issuance of
common stock through...
$16K
(-79.75%↓ Y/Y)
Net cash used in
operating activities
-$9,351K
(68.10%↑ Y/Y)
Net cash (used in)
provided by financing...
-$129K
(-100.35%↓ Y/Y)
Canceled cashflow
$1,627K
Canceled cashflow
$16K
Consolidated net loss
-$10,310K
(70.04%↑ Y/Y)
Principal paid on finance
lease liabilities
$145K
(-45.08%↓ Y/Y)
Accounts payable and
accrued expenses
-$266K
(-154.85%↓ Y/Y)
Operating lease liability
-$208K
(39.00%↑ Y/Y)
Accretion of discount of
available-for-sale investment...
$146K
(-85.12%↓ Y/Y)
Gain on financing
lease bargain...
$48K
Buy us a coffee
aTYR PHARMA INC (ATYR)
aTYR PHARMA INC (ATYR)